HBOT News & Research

Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation.  Use the search or select an article below to keep up to date on the most recent HBOT News.

Recent Hyperbaric Oxygen Therapy (HBOT) News

[Bevacizumab for the treatment of cerebral radionecrosis].

Abstract: Bevacizumab is a monoclonal antibody, which neutralizes the effect of vascular endothelium growth factor (VEGF) allowing regression of tumour vessels and a decrease in the permeability of the blood-brain barrier. Already used in oncology...